Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Cheryl Galt who wrote (29400)	11/16/1999 9:17:00 AM
From: Alper H.YUKSEL	Read Replies (2) \| Respond to of 32384

Cheryl, I believe that weak Panretin sales were already discounted during the quarter, when the price was languishing at 7 and change. Therefore, I don't believe that we'll go below that level at least for now. I think the main problem is the cash burn rate now. LGND needs to get some good results on the clinical front in order to survive. Next year will probably be the pivotal year for LGND's future. I am fine BTW as far as the earthquakes are concerned. Pres. Clinton is here this week and local papers have written that his hotel room has been strengthened with a steel cage. Cheers, Alper

To: Cheryl Galt who wrote (29400)	11/16/1999 9:20:00 AM
From: Webhead	Respond to of 32384

Well the overnight Instanet value of 10 1/2 was from a single trade of 500 shares and a large jump over the 10 3/16 previous price. Before the open, we're down to 10 X 10 1/16 so it ain't so rosy... Ed